Amanote Research
Register
Sign In
177. Deletions of Both Vaccinia Growth Factor and O1 Protein Genes Enhance Therapeutic Index of Oncolytic Vaccinia Virus
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35190-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Rational Combination of Oncolytic Vaccinia Virus and PD-L1 Blockade Works Synergistically to Enhance Therapeutic Efficacy
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Vaccinia Virion Protein I8R Has Both DNA and RNA Helicase Activities: Implications for Vaccinia Virus Transcription.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Cancer Research
Cancer Research
Oncology
Oncolytic Vaccinia Virus as a Vector for Therapeutic Sodium Iodide Symporter Gene Therapy in Prostate Cancer
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts Following Treatment With Oncolytic Vaccinia Virus GLV-1h68
Journal of Oncology
Oncology
Recombinant Oncolytic Vaccinia Viruses Expressing Human Β-Defensin 2 Enhance Anti-Tumor Immunity
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Vaccinia Virus Motility
Annual Review of Microbiology
Microbiology
Vaccinia Virus Virulence Factor N1L Is a Novel Promising Target for Antiviral Therapeutic Intervention
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Growth Inhibition of Different Human Colorectal Cancer Xenografts After a Single Intravenous Injection of Oncolytic Vaccinia Virus GLV-1h68
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology